Sino Select Value Mixed Securities Investment Fund (abbreviation: Sino Select Value Mixed A, code 001900) announced its latest net value on April 1, up 6.11%.
Sino Analytica Select Value Mix A was established on February 28, 2019, and the performance comparison benchmark is the return rate of the CSI 300 Index ×50% + the return rate of the Hang Seng Index ×30% + the return rate of the China Bond Composite Wealth Index ×20%. The fund has returned 36.99% since its inception, 39.97% this year, 15.70% over the past month, 35.58% over the past year, and 5.98% over the last three years. In the past year, the fund ranked 235/7808 in its peer group.
The fund manager is Tang Chen. Tang Chen has managed (or intends to manage) the fund since December 20, 2022, with a return of 10.47% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 01801 | Innovent | 7.77% | 270411 | 9.1651 million |
| 09926 | Akeso | 7.19% | 151008 | 8.4883 million |
| 06990 | Columbotai Bio-B | 7.05% | 55007 | 8,318,300,013 |
| Chi-Med | 6.90% | 389798 | 8,139,800 | |
| 688235 | BeiGene | 6.16% | 45141 | 7.2686 million |
| 300558 | Betta Pharmaceuticals | 5.63% | 123300 | 6.6496 million |
| 688382 | Yifang Biotech | 5.52% | 489702 | 6.513 million |
| 688506 | Baili Tianheng | 5.43%, | 33431 | 6.4097 million |
| 688266 | Zejing Pharmaceuticals | 5.30% | 100299 | 6.2496 million |
| 688428 | InnoCare | 5.09% | 489053 | 6.0056 million |
Ticker Name
Percentage Change
Inclusion Date
